Comment · Sat, May 11, 2019
Semax
Original post in this thread
alwaysandeverywhere · 1 points
Any chance ND will offer Semax at some point? And/or Selank? It sure could use some quality control...
What they were answering
Direct reply to the original post — see the thread post above.
u/MisterYouAreSoDumb
No way I would ever offer peptides on ND. That's why I shut Ceretropic down. I'd bring back Ceretropic before I brought the products to ND. Don't get excited. That's not something I am considering, either. Exactly what I said was going to happen is happening. There is no incentive for quality control in the peptide or SARM space anymore, so nobody is going to spend the money to do it. It's very very expensive and complicated to do properly. I've spent many millions of dollars on our lab, and continue to dump a lot of funding into it regularly. Nobody else is going to put up that kind of money in a risky space like peptides; not with the legal and regulatory environment the way it is currently. I wish things were different, but doing what I did with Ceretropic was a pretty rare occurrence. I did it because I was passionate about it. However, sometimes you have to be pragmatic and let some of your passions go, to allow room for different ones to take hold. My current focus is in a totally different area, and is has to be for the sustainability of the company. Peptides still interest me, and I may go back to them at some point. However, that time is not now.
We are doing some crazy cool shit these days! Our lab is becoming a world-class operation under my new lab director. We are doing things I never even knew existed a few years ago. I realize it may not look as interesting to the outside as when we were constantly bringing out novel peptides and other compounds, but we are in a completely different league now. I have not been around here as much getting people excited about what is going on, but we really are doing some insanely cool things. I wish I could help improve the standards in the peptide space, but that's just not in the cards at the moment.